The protocol design is important as it dictates the way a study will be conducted.
Richmond Pharmacology’s Advanced Research Science Department has considerable experience in compiling Clinical Study Protocols according to ICH guidelines. Each protocol is developed in collaboration with the Sponsor in order to fulfil the trial requirements and objectives.
All protocols are written by Richmond Pharmacology’s Advanced Research Science team, with input from Richmond Pharmacology’s Research Physicians and Principal Investigators.
Our experienced Clinical Research Scientists will ensure your study design meets the specified end points by the most efficient method.
Futureproofing early phase clinical research for the next generation of investigators.
March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.